Name: UMIN ID:
Unique ID issued by UMIN | C000000196 |
---|---|
Receipt number | R000000270 |
Scientific Title | Efficacy of combination therapy IFN-alpha-2b and ribavirin for patients with Serogroup2 and high titer HCV / without Serogroup1 and high titer HCV. |
Date of disclosure of the study information | 2008/12/31 |
Last modified on | 2019/08/02 15:11:34 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2005/09/13 02:49:25 | ||
2 | Update | 2016/09/30 15:41:16 | Last name of lead principal investigator Last name of lead principal investigator Division name TEL Last name of contact person Last name of contact person Division name TEL Name of person sending information Name of person sending information Organization Division name Address Address TEL Name of primary person or sponsor Organization Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
3 | Update | 2016/09/30 15:45:44 | UMIN ID1 |
|
4 | Update | 2018/07/31 21:55:58 | Recruitment status |
|
5 | Update | 2019/08/02 15:11:34 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization1 Address1 Tel1 Email1 Organization Organization Address Address Tel |